2009 Marks 50 Years of Innovative 'Firsts' for Instrumentation Laboratory

-- In Vitro Diagnostics Leader Celebrates 50th Anniversary --

LEXINGTON, Mass., Jan. 12 /PRNewswire/ -- Instrumentation Laboratory (IL), a
worldwide developer, manufacturer and distributor of in vitro diagnostic
instruments, related reagents and services, is celebrating the anniversary
date of its founding, fifty years ago today. The company launched its "50 and
Forward" celebration in 2008 and will continue the program through its
anniversary year with events that reflect on IL's 50 years of historic
achievements, as well as its plans for continued innovation in the future.

IL's Distinguished History of "Firsts"
From its earliest days, IL's notable breakthroughs have had a major impact in
laboratory medicine and the well-being of patients around the world. Its
first instrument, the IL 113, launched a new era of automation in the
industry, and set the stage for IL's constant innovation for half a century.
From the revolutionary IL 113 blood gas analyzer, to the IL 143 flame
photometer, to the invention of CO-Oximetry, IL launched products that
replaced time-consuming manual techniques, setting new standards in hospitals
worldwide.

Today, around the globe, IL's innovative products impact hospitals, and their
central laboratories, ICUs, operating rooms and emergency rooms, bringing
automation and accuracy to caregivers and the patients that rely on them. The
same passion and dedication to innovation that led IL's earliest missions are
what the company is celebrating in 2009, with a renewed commitment to
continuing this legacy in the future.

"We're proud that IL's history of 'firsts' has played a part in
revolutionizing the world of medical diagnostics across the globe. Patients
and caregivers benefit from our discoveries on nearly every continent, every
single day," said Josep Manent, CEO of IL. "Year after year, product after
product, IL is recognized as having set new standards in diagnostic testing."

Ramon Benet, VP of Worldwide Marketing and US Sales and Service at IL, added,
"The '50 and Forward' program not only celebrates our history, but embodies
our commitment to the future of diagnostics - IL will continue to meet the
changing needs of the in vitro diagnostic market, today and into the future."

Another IL "First" to be Introduced in Europe during Q1, 2009
As the world's leading developer of hemostasis testing systems, IL plans to
begin 2009 with the launch of another innovative addition to its ACL family of
hemostasis testing instruments, that use 'chemiluminescence' technology to
automate specialty assays:

-- The highly-anticipated ACL AcuStar(TM), the first fully automated
random-access chemiluminescence analyzer dedicated to specialty assays
in hemostasis

"Passion and Results" Award Nominations for IL Customers Accepted thru June
1st.
The cornerstone of IL's 50th anniversary celebration is the "Passion and
Results" Award for customers. Three laboratorians, respiratory therapists,
physicians or nurses who have demonstrated remarkable passion and dedication
resulting in enhanced patient care will receive an award and an educational
grant to their institution. Industry professionals are invited to submit an
inspiring story of patient care - about themselves or another person - by
completing IL's "Passion and Results" nomination form available through an IL
sales representative or online at www.ilus.com/50forward. Submissions will be
accepted through June 1, 2009 and are open to all worldwide customers. Winners
will be honored in July, 2009.

ILeader Panel of Experts Available to Industry.
IL's leadership in the development of diagnostic instruments is largely due to
its many renowned thought leaders. Members of the "50 and Forward" ILeader
Panel of esteemed experts in a variety of diagnostics-related areas are
available to contribute to the betterment of diagnostics through forums,
webcasts, roundtables, seminars and press comments throughout IL's 50th
anniversary celebration year. Persons and publications interested in securing
the ILeader Panel's services should contact IL's Sally McCraven at
781-861-4577, smccraven@ilww.com.

About Instrumentation Laboratory
Instrumentation Laboratory (www.ilus.com), founded in 1959, is a worldwide
developer, manufacturer and distributor of in vitro diagnostic instruments,
related reagents and controls for use primarily in hospitals and independent
clinical laboratories. The company's product lines include critical care
systems, hemostasis systems and information management systems.

IL's GEM(R) product offerings, part of the critical care line, include the new
GEM Premier(TM) 4000 analyzer with Intelligent Quality Management (iQM(R)),
GEM Premier 3000 analyzer, GEM OPL(TM), a portable whole blood CO-Oximeter and
the GEM PCL Plus, a portable coagulation analyzer. IL's hemostasis portfolio
includes the ACL TOP(R) Family of Hemostasis Testing Systems, fully automated,
high-productivity analyzers, including the ACL TOP and the new ACL TOP 500
CTS. IL also offers the ACL ELITE(R) and ELITE PRO, other hemostasis
analyzers and the HemosIL(R) line of reagents. IL is based in Lexington,
Massachusetts.

The Instrumentation Laboratory logo, GEM, iQM, HemosIL, ACL TOP, ACL ELITE,
Premier and GEM OPL are trademarks of Instrumentation Laboratory Company
and/or one of its subsidiaries or parent companies, and may be registered in
the United States Patent and Trademark Office and in other jurisdictions. All
other product names, company names, marks, logos, and symbols are trademarks
of their respective owners.

SOURCE Instrumentation Laboratory

Sally McCraven of Instrumentation Laboratory, +1-781-861-4577,
smccraven@ilww.com or Luisa Cahill of Kelley, Habib, John for Instrumentation
Laboratory, +1-617-921-8087, lcahill@khj.com